Lazertinib

• Description:

  Lazertinib (YH25448, GNS-1480) is a highly potent, mutant-selective, irreversible, brain-penetrant and orally active EGFR tyrosine-kinase inhibitors for both the T790M mutation and activating EGFR mutations.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  554.66

• Molecular Formula:

  C30H34N8O3

• Notes:

  Research use only, not for human use.

• Receptor:

  EGFR (del19) |EGFR (T790M) |EGFR (T790M/L858R)

• CAS Number:

  1903008-80-9